OTC: SCTH

Securetech Innovations, Inc.

CIK 0001703157 · SIC 3714 · Motor Vehicle Parts & Accessories

Micro Revenue $8M Assets $21M as of Sep 20, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (CALM 10-Q) is open in full — no account needed.

10-K/A Filed Sep 23, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

S-1 Filed Sep 9, 2026

Summary not yet generated.

Partner

Trade SCTH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed Aug 19, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 17, 2026 · Period ending Aug 13, 2026

Summary not yet generated.

10-Q/A Filed Aug 6, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K/A Filed Aug 6, 2026 · Period ending Dec 31, 2025 Red flag

revenue $7.7M, net income $203,298. SecureTech 10-K/A restates FY2025 financials, adds material weakness and going-concern warning

5 material changes detected. Sign up free to read the summary.

8-K Filed Aug 5, 2026 · Period ending Jul 31, 2026

Summary not yet generated.

10-Q/A Filed Aug 5, 2026 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q/A Filed Aug 5, 2026 · Period ending Jun 30, 2025

Summary not yet generated.

8-K Filed Jun 10, 2026 · Period ending Jun 5, 2026

Summary not yet generated.

10-Q Filed May 15, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed May 12, 2026 · Period ending May 8, 2026

Summary not yet generated.

8-K Filed Apr 16, 2026 · Period ending Apr 13, 2026

Summary not yet generated.

8-K Filed Apr 10, 2026 · Period ending Apr 6, 2026

Summary not yet generated.

10-K Filed Mar 25, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 20, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-K Filed Mar 31, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-K/A filed Sep 23, 2026 (period ending Dec 31, 2025). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statements of Operations

(in dollars, except per share amounts; mapped from filer XBRL tags, not printed on the filing face)

Description Year ended Dec 31, 2025 Year ended Dec 31, 2024 Year ended Dec 31, 2023
Revenue:
Total revenue / net sales 7,720,757 14,235 48,024
Cost of revenue / cost of sales 5,818,498 3,421 12,429
Gross profit 1,902,259 10,814 35,595
Operating expenses:
Demand creation / marketing 7,485 43,419
Research and development 280,261 8,501
Operating overhead 1,366,109 414,400 395,358
Selling, general and administrative 20,569
Total operating expenses 1,666,939 414,400 403,859
Operating income 235,320 (403,586) (368,264)
Interest expense 4,020
Other income/(expense), net (149,612) (5,854) (206.00)
Income before income taxes 85,708 (409,440)
Income tax expense/(benefit) (117,590)
Net income 179,409 (409,440) (368,470)
Net income attributable to shareholders 203,298 (409,440) (368,470)
Basic earnings per share — (0.01) —
Diluted earnings per share — (0.01)

Consolidated Balance Sheets

Description December 31, 2025 (Restated – See Note 2) December 31, 2024
Current assets:
Cash and equivalents 233,825 —
Accounts receivable, net 1,933,221 —
Amounts due from related parties 24,098 —
Inventories 1,946,203 —
Prepayments and other current assets 3,383,422 1,114
Total current assets 7,520,769 1,114
Non-current assets:
Equipment, net 312,229 2,503
Operating lease right-of-use, net 291,444 —
Intangible assets, patents 3,485,120 —
Goodwill 6,278,366 —
Accounts receivable, net of non-current portion 1,185,097
Deferred tax asset 117,177 —
Total non-current assets 11,669,433 2,503
Total assets: 19,190,202 3,617
Current liabilities:
Accounts payable 1,483,093 14,205
Accounts payable, related parties 63,113 50,978
Accrued payroll, related parties 59,498 322,448
Amounts due to related parties 4,581 —
Contract liabilities 164,336 —
Notes payable 551,822 —
Notes payable, related parties 192,464 39,611
Operating lease liabilities, current portion 99,298
Short-term borrowings 2,499,607 —
Accrued expenses and other current liabilities 1,254,422 16,417
Total current liabilities 6,372,234 443,659
Non-current liabilities:
Operating lease liabilities, net of current portion 194,720 —
Deferred tax liabilities 548,190 —
Total non-current liabilities 742,910 —
Total liabilities: 7,115,144 443,659
Mezzanine equity:
Redeemable non-controlling interest 738,303 —
Stockholders’ equity (deficit):
Preferred stock, $0.001 par value, 50,000,000 shares authorized; 18,295 and 13,400 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 18 13
Common stock, $0.001 par value, 500,000,000 shares authorized; 31,377,368 and 78,086,881 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 31,377 78,087
Contingent consideration 1,652,910 —
Additional paid in capital 10,442,707 1,196,426
Accumulated deficit (1,601,791) (1,714,568)
Accumulated other comprehensive loss 76,892 —
Total equity attributable to:
SecureTech shareholders 10,602,113 (440,042)
Non-controlling interests 734,642 —
Total stockholders’ equity (deficit) 11,336,755 (440,042)
Total liabilities and stockholders’ equity 19,190,202 3,617

Consolidated Statements of Cash Flows

(in dollars, except per share amounts; mapped from filer XBRL tags, not printed on the filing face)

Description Year ended Dec 31, 2025 Year ended Dec 31, 2024
Investing Activities:
Net cash from investing activities 135,404
Financing Activities:
Net cash from financing activities 945,779 54,611
Effect of exchange rate changes 75,213
Net increase/(decrease) in cash 158,615 (5,987)

Statements found on the EDGAR/iXBRL face print as filed; the rest are presentation-friendly mappings of filer XBRL tags, at the scale noted on each table. EPS as reported. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗